NO965457D0 - Nye opioid peptidantagonister - Google Patents

Nye opioid peptidantagonister

Info

Publication number
NO965457D0
NO965457D0 NO965457A NO965457A NO965457D0 NO 965457 D0 NO965457 D0 NO 965457D0 NO 965457 A NO965457 A NO 965457A NO 965457 A NO965457 A NO 965457A NO 965457 D0 NO965457 D0 NO 965457D0
Authority
NO
Norway
Prior art keywords
peptide antagonists
opioid peptide
novel opioid
novel
antagonists
Prior art date
Application number
NO965457A
Other languages
English (en)
Norwegian (no)
Other versions
NO965457L (no
Inventor
Peter Schiller
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9402170A external-priority patent/SE9402170D0/xx
Priority claimed from SE9402838A external-priority patent/SE9402838D0/xx
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO965457D0 publication Critical patent/NO965457D0/no
Publication of NO965457L publication Critical patent/NO965457L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO965457A 1994-06-20 1996-12-18 Nye opioid peptidantagonister NO965457L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9402170A SE9402170D0 (sv) 1994-06-20 1994-06-20 New compounds
SE9402838A SE9402838D0 (sv) 1994-08-25 1994-08-25 New compounds
PCT/SE1995/000721 WO1995035316A1 (en) 1994-06-20 1995-06-14 New opioid peptide antagonists

Publications (2)

Publication Number Publication Date
NO965457D0 true NO965457D0 (no) 1996-12-18
NO965457L NO965457L (no) 1996-12-18

Family

ID=26662082

Family Applications (1)

Application Number Title Priority Date Filing Date
NO965457A NO965457L (no) 1994-06-20 1996-12-18 Nye opioid peptidantagonister

Country Status (8)

Country Link
US (1) US5733881A (ja)
JP (1) JPH10501807A (ja)
CA (1) CA2192484A1 (ja)
FI (1) FI965116A0 (ja)
IL (1) IL114046A0 (ja)
NO (1) NO965457L (ja)
NZ (1) NZ288775A (ja)
WO (1) WO1995035316A1 (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001036006A1 (en) * 1999-11-19 2001-05-25 Palatin Technologies, Inc. Opioid metallopeptide compositions and methods
US6284769B1 (en) 1999-12-03 2001-09-04 The Board Of Trustees Of The University Of Illinois Nonpeptide kappa opioid receptor antagonists
EP1613597B1 (en) 2003-03-07 2007-11-07 Eli Lilly and Company 6-substituted nicotinamide derivatives as opioid receptor antagonists
US7601739B2 (en) 2003-08-08 2009-10-13 Virgina Commonwealth University Compounds having antiestrogenic and tissue selective estrogenic properties, and compounds with anti-androgenic properties for treatment of prostate cancer and androgen receptor dependent diseases
WO2005016889A1 (en) * 2003-08-08 2005-02-24 Virginia Commonwealth University Compounds having antiestrogenic and tissue selective estrogenic properties

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9300012D0 (sv) * 1993-01-05 1993-01-05 Astra Ab New peptides

Also Published As

Publication number Publication date
AU691630B2 (en) 1998-05-21
AU2811495A (en) 1996-01-15
NZ288775A (en) 1998-02-26
FI965116L (fi) 1996-12-19
FI965116A7 (fi) 1996-12-19
CA2192484A1 (en) 1995-12-28
JPH10501807A (ja) 1998-02-17
IL114046A0 (en) 1995-10-31
NO965457L (no) 1996-12-18
US5733881A (en) 1998-03-31
FI965116A0 (fi) 1996-12-19
WO1995035316A1 (en) 1995-12-28

Similar Documents

Publication Publication Date Title
NO980592D0 (no) Nye opioidpeptider
FI971685L (fi) Takykiniini-antagonisteja
NO972494D0 (no) Nye pinnsvin-avledete polypeptider
FI970107L (fi) Heterosyklisiä takykiniinireseptoriantagonisteja
FI970523A7 (fi) (Atsetidin-1-yylialkyyli)laktaamit takykiniiniantagonisteina
FI962074A7 (fi) Takykiniinireseptorin ei-peptidi-antagonisteja
EE9600186A (et) Neurokiniini (tahhüülkiniini) antagonistid
FI955258L (fi) Takykiniiniantagonisteina käyttökelpoisia substituoituja pyrrolidiini-3-yl-alkyyli-piperidiineja
FI946140L (fi) Diatsabisyklisiä neurokiniiniantagonisteja
PT805813E (pt) Antagonistas de vasopressina triciclicos
FI960727L (fi) Neurokiniiniantagonisteina käyttökelpoiset heterosyklit
FI962489A7 (fi) Morfoliini-ja tiomoforfoliinitakykiniinireseptoriantaginisteja
NO970512D0 (no) Nye heteroaryl-oksazolidinoner
EP0866705A4 (en) FIBRINOGENIC RECEPTOR ANTAGONISTS
FI960516L (fi) Substituoituja bifenyylisulfonamidiendoteliiniantagonisteja
NO952650D0 (no) Nye peptider
FI945378A7 (fi) Bombesiinin polypeptidiantagonistit
ATE232526T1 (de) 3-azetidinylalkylpiperidine oder -pyrrolidine als tachykinin antagonisten
DK0770132T3 (da) Nye streptograminer
FI953916A7 (fi) Fibrinogeenireseptoriantagonisteja
NO179550C (no) Tachykinin reseptorantagonister
DE69513832D1 (de) Exzitatorische aminosäure-rezeptor-antagonisten
DK158390D0 (da) Nye peptider
DE69732715D1 (de) Tachykinin antagoniste
NO965457D0 (no) Nye opioid peptidantagonister

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application